Drugs Made In America Acquisition logo

Drugs Made In America Acquisition

DMAA | NASDAQ
Chart Builder DCF Calculator
$10.90
$0.00 (0.00%)
At close: Nov 16, 2026, 4:00 PM ET
$10.89
-$0.01 (-0.09%)
After-hours: Nov 16, 2026, 4:37 PM ET
+0.00%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
11.2
+1.4 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #1256/1269 (Top 99%)

Key Statistics

Market Data

Market Cap $264.62M
1D Range
10.89 10.93
52W Range
10.32 10.93

Valuation (TTM)

PE 54.50
PB 1.92
EV/EBITDA -100.84

Valuation (NTM)

Forward PE N/A
Forward PEG -0.56
Price Target $0.00
Loading financial charts...

Profile

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or oth...

Employees 2
IPO Date Jan 27, 2025
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.